These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway. Geng D; Zhao W; Feng Y; Liu J Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539 [TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells. Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262 [TBL] [Abstract][Full Text] [Related]
5. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
6. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway. Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X Tumour Biol; 2014 Jun; 35(6):5189-98. PubMed ID: 24573607 [TBL] [Abstract][Full Text] [Related]
8. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
9. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway. He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229 [TBL] [Abstract][Full Text] [Related]
10. Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma. Shi W; Huang W; Chen Y; Zhang S; Xu P; Gu X; Fan H; Xu J; Chen Y; Ni R; Lu C; Zhang X Tumour Biol; 2016 Aug; 37(8):10447-57. PubMed ID: 26846109 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
13. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C; Guo F; Xu G; Ma J; Shao F Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024 [TBL] [Abstract][Full Text] [Related]
14. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling. Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701 [TBL] [Abstract][Full Text] [Related]
15. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630 [TBL] [Abstract][Full Text] [Related]
16. Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells. Wu WR; Zhang R; Shi XD; Yi C; Xu LB; Liu C Oncol Rep; 2016 Jul; 36(1):181-8. PubMed ID: 27221981 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2. Zhang L; Wang W; Li X; He S; Yao J; Wang X; Zhang D; Sun X Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Chang RM; Xu JF; Fang F; Yang H; Yang LY Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561 [TBL] [Abstract][Full Text] [Related]
20. Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways. Zhao B; Zhao W; Wang Y; Xu Y; Xu J; Tang K; Zhang S; Yin Z; Wu Q; Wang X Oncotarget; 2015 Apr; 6(12):10116-33. PubMed ID: 25426556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]